Sydney Rosen
Profiles

Sydney B Rosen, MPA

Research Professor, Global Health - Boston University School of Public Health

617-358-2251
sbrosen@bu.edu
Crosstown Center - 380
View Full Profile at BUMC

Biography

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health at the Boston University School of Public Health and a Co-Director of the Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, and in particular the outcomes, costs, cost-effectiveness, and benefits of HIV and TB care and treatment interventions and models of service delivery. She is the principal investigator of multiple USAID-, NIH-, and foundation-supported studies and evaluations in South Africa and has worked extensively in Zambia, Malawi, and Kenya. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in HIV/AIDS care and treatment programs. Her current projects include AMBIT, EVIDENCE, and EQUIP, all described on the BUSPH website. Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.

Other Positions

  • Co-Division Head, Health Economics and Epidemiology Research Office - University of the Witwatersrand

Education

  • Harvard University, MPA Field of Study: Economics
  • Harvard University, AB Field of Study: History

Websites

Publications

  • Published on 9/23/2025

    Kachingwe E, Mutanda N, Ntjikelane V, Benade M, Manganye M, Malala L, Rosen S, Maskew M. Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa. PLOS Glob Public Health. 2025; 5(9):e0004927. PMID: 40986527.

     Read At: PubMed
  • Published on 9/1/2025

    Zheng A, Kileel EM, Brennan AT, Flynn DB, Rosen S, Fox MP. Systematic review and meta-analysis of retention and disengagement after initiation on antiretroviral therapy in low- and middle-income countries after the introduction of Universal Test and Treat policies. J Int AIDS Soc. 2025 Sep; 28(9):e70026. PMID: 40908808.

     Read At: PubMed
  • Published on 8/27/2025

    Ngoma T, Kamanga A, Scott N, Morgan A, Reddy Marri A, Makwalu T, Mulenga L, Sivile S, Benade M, Haimbe P, Shakwelele H, Rosen S. Advanced HIV disease during the first six months on antiretroviral therapy in Zambia: research protocol for a prospective, observational, multi-cohort study. Gates Open Res. 2025; 9:66. PMID: 40896557.

     Read At: PubMed
  • Published on 8/26/2025

    Huber AN, Jamieson L, Fox MP, Manganye M, Malala L, Chidarikire T, Khoza N, Nichols BE, Rosen S, Pascoe S. Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data. PLoS Med. 2025 Aug; 22(8):e1004489. PMID: 40857347.

     Read At: PubMed
  • Published on 8/11/2025

    Benade M, Maskew M, Chilembo P, Wa Mwansa M, Savory T, Nichols B, Bolton C, Mulenga LB, Sivile S, Zyambo KD, Rosen S. Patterns of engagement in care during clients' first 12 months after HIV treatment initiation in Zambia: a retrospective cohort analysis using routinely collected data. BMJ Glob Health. 2025 Aug 11; 10(8). PMID: 40789714.

     Read At: PubMed
  • Published on 7/26/2025

    Benade M, Maskew M, Ntjikelane V, Scott N, Ngcobo N, Nichols B, Malala L, Manganye M, Rosen S. Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators of exposure. BMC Infect Dis. 2025 Jul 26; 25(1):947. PMID: 40713520.

     Read At: PubMed
  • Published on 7/1/2025

    Lekodeba NA, Rosen S, Phiri B, Masuku SD, Govathson C, Kamanga A, Haimbe P, Shakwelele H, Mwansa M, Lumano-Mulenga P, Huber AN, Pascoe SJS, Jamieson L, Nichols BE. Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data. J Int AIDS Soc. 2025 Jul; 28(7):e70003. PMID: 40579870.

     Read At: PubMed
  • Published on 7/1/2025

    Mokgethi O, Huber A, Mokhele I, Shumba K, Ntjikelane V, Rosen S, Pascoe S. Aligning HIV treatment and hypertension clinic visits and dispensing as a first step towards service delivery integration in South Africa. J Int AIDS Soc. 2025 Jul; 28 Suppl 3(Suppl 3):e26444. PMID: 40879611.

     Read At: PubMed
  • Published on 6/25/2025

    Mokhele I, Ntjikelane V, Scott NA, Kaiser JL, Morgan AJ, Huber A, Mokgethi NO, Tchereni TH, Phiri W, Kamanga A, Haimbe PM, Lumano-Mulenga P, Nyirenda RK, Pascoe SJS, Rosen S. Are HIV Treatment Clients Offered a Choice of Differentiated Service Delivery Models? Evidence from Malawi, South Africa, and Zambia. Patient Prefer Adherence. 2025; 19:1825-1841. PMID: 40585576.

     Read At: PubMed
  • Published on 5/26/2025

    Ntjikelane V, Phiri B, Kaiser JL, Rosen S, Morgan AJ, Huber A, Mokhele I, Tchereni T, Ngoma S, Lumano-Mulenga P, Pascoe S, Scott N. Effect of differentiated service delivery models for HIV treatment on healthcare providers' job satisfaction and workloads in sub-Saharan Africa: a mixed methods study from Malawi, Zambia, and South Africa. Hum Resour Health. 2025 May 26; 23(1):25. PMID: 40420127.

     Read At: PubMed

View 171 more publications:View Full Profile at BUMC

News & In the Media

View all profiles